Restricted accessResearch articleFirst published online 2011-12
Oral Administration of an Enzymatic Protein Hydrolysate from the Green Microalga Chlorella vulgaris Enhances the Nutritional Recovery of Malnourished Mice
This study examined the effects of oral administration of an enzymatic protein hydrolysate from green microalga Chlorella vulgaris (Cv-PH) on the nutritional recovery of malnourished Balb/c mice after a 3-day fasting period. Mice were refed with commercial diet supplemented or not supplemented with Cv-PH (500 mg/kg) for 8 days. Regardless of the diet used during refeeding, animal body weights and serum protein concentrations did not differ between groups. Mice given Cv-PH had a significant increase in hemoglobin concentrations. Most serum amino acid levels were similar in the control and Cv-PH animals. Starved mice refed with Cv-PH showed normal liver functions, as judged by liver weight, protein concentration, and the enzymatic activities of cholinesterase and arginase. Cv-PH increased DNA, protein content, and gut-mucosal weight. In addition, brush-border oligosaccharidase activities were also higher in the Cv-PH group. These findings suggest that Chlorella protein hydrolysate can be used to develop specific formulations suitable for pharmacologic nutrition.
Get full access to this article
View all access options for this article.
References
1.
PulzO, ScheibenbogenK, GrossW. Biotechnology with cyanobacteria and microalgae. Biotechnology, 2ndRehmHJ, ReedG. Wiley-VCH: Weinheim, Germany, 2000; 105–136.
2.
OlaizolaM. Commercial development of microalgal biotechnology: from the test tube to the marketplace. Biomol Eng, 2003; 20:459–466.
3.
ShimizuY, LiB. Microalgae as a source of bioactive molecules: special problems and methodology. Frontiers in Marine Biotechnology. ProkschP, MuellerWEG. Horizon Biosciences: Wymondham, United Kingdom, 2006; 145–174.
IwamotoH. Industrial production of microalgal cell-mass and secondary products—Major industrial species—Chlorella. Handbook of Microalgae Biotechnology. RichmondA. Blackwell Publishing: Oxford, 2003; 255–263.
6.
PulzO, GrossW. Valuable products from biotechnology of microalgae. Appl Microbiol Biotechnol, 2004; 65:635–648.
7.
TchorbanovB, BozhkovaM. Enzymatic hydrolysis of cell proteins in green algae Chlorella and Scenedesmus after extraction with organic solvents. Enzyme Microb Technol, 1988; 10:233–238.
8.
StoilovIL, GeorgievTD, TaskovMV, KolevaID. Oral preparation for patients with chronic renal insufficiency, other protein metabolic diseases. W.O. Patent 95/2952, November2, 1995.
9.
FrokjaerS. Use of hydrolysates for protein supplementation. Food Technol, 1994; 48:86–88.
10.
VioqueJ, PedrocheJ, YustMMet al.Peptideos bioativos em proteínas vegetais de reserve. Braz J Food Technol, 2004; 2:99–102.
11.
BiziuleviciusGA. How food-borne peptides may give rise to their immunostimulatory activities: a look through the microbiologist's window into the immunologist's garden (hypothesis)Br J Nutr, 2004; 92:1009–1012.
12.
KimSK, WijesekaraI. Development and biological activities of marine-derived bioactive peptides: a review. J Funct Foods, 2010; 2:1–9.
13.
MorrisHJ, AlmaralesA, CarrilloO, BermúdezRC. Utilisation of Chlorella vulgaris cell biomasa for the production of enzymatic protein hydrolysates. Biores Technol, 2008; 99:7723–7729.
14.
MorrisHJ, CarrilloO, BermúdezRCet al.Immunostimulant activity of an enzymatic protein hydrolysate from green microalga Chlorella vulgaris on undernourished mice. Enzyme Microb Technol, 2007; 40:456–460.
15.
MorrisHJ, CarrilloO, AlonsoME, BermúdezRC. Are the peptide sequences encrypted in food Chlorella protein a possible explanation for the immunostimulatory effects of microalgal supplements?Med Hypoth, 2008; 70:896.
16.
ShilsME, ShikeM, RossAC, CaballeroB, CousinsRJ. Modern Nutrition in Health and Disease, 10th. Lippincott Williams & Wilkins: Philadelphia, 2005.
17.
MorrisHJ, CarrilloOV, LlauradóGet al.Effect of starvation, refeeding on biochemical, immunological status of Balb/c mice: an experimental model of protein-energy malnutrition. Immunopharmacol Immunotoxicol, 2010Nov25[Epub ahead of print].
ScholzeT. Determination of phenylthiocarbamil amino acids by reverse-phase high-performance liquid chromatography. J Chromatogr, 1985; 350:453–460.
20.
LowryOH, RosenbroughNJ, FarrAL, RandallRJ. Protein measurement with the Folin phenol reagent. J Biol Chem, 1951; 193:265–275.
21.
OkulovV, MoralesMG, LlanioR. Bioquímica en Gastroenterología. Editorial Pueblo y Educación: Havana, Cuba, 1991.
22.
BurtonK. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of DNA. Biochem J, 1956; 62:315–323.
23.
DahlquistA. Assay of intestinal disaccharidases. Anal Biochem, 1968; 22:99–107.
24.
BozaJJ, MoennozD, VuichoudJet al.Food deprivation and refeeding influence growth, nutrient retention and functional recovery of rats. J Nutr, 1999; 129:1340–1346.
25.
Kallai-SanfaçonMA, LacroixGL, TremblayF. Malnutrition screening and post treatment follow-up of hospitalised patients 65 years and older: the role of albumin and pre-albumin as biochemical markers. Clin Biochem, 2000; 33:229–230.
26.
DonBR, KaysenG. Serum albumin: relationship to inflammation and nutrition. Semin Dial, 2004; 17:432–437.
27.
RahmanMZ, BegumBA. Serum total protein, albumin and a/g ratio in different grades of protein energy malnutrition. Mymensingh Med J, 2005; 14:38–40.
28.
LippJ, SaxHC. Novel (immune) nutrients in critical illness. Nutrition Support for the Critically Ill Patient. CresciG. CRC Press: Boca Raton, FL, USA, 2005; 173–189.
29.
BozaJJ, Martínez-AugustinaO, BaróL, SuárezMD, GilA. Protein vs enzymic protein hydrolysates. Nitrogen utilization in starved rats. Br J Nutr, 1995; 73:65–75.
30.
MurrayRK, GrannerDK, MayesPH, RodwelVW. Harper's Illustrated Biochemistry, 26th. Lange Medical Books/McGraw-Hill: New York, 2003.
31.
RothE, WessnerB. L-Arginine: an amino acid with multiple effects. Wiener Klin Wochenschr, 2005; 117:666–672.
32.
Cahill-MorascoR, HoffmanRS, GoldfrankLR. The effects of nutrition on plasma cholinesterase activity and cocaine toxicity in mice. J Toxicol Clin Toxicol, 1998; 36:667–672.
33.
CalbetJA, HolstJJ. Gastric emptying, gastric secretion and enterogastrone response after administration of milk proteins or their peptide hydrolysates in humans. Eur J Nutr, 2004; 43:127–139.
34.
ManninenAH. Protein hydrolysates in sports and exercise: a brief review. J Sports Sci Med, 2004; 3:60–63.
35.
CummingsJH, AntoineJM, AspirozF. PASSCLAIM – Gut health and immunity. Eur J Nutr, 2004; 43:118–173.
36.
BaumC, MoxonD, ScottM. Enfermedades gastrointestinales. Conocimientos Actuales Sobre Nutrición, 8thBowmanB, RussellA. Organización Panamericana de la Salud: Washington, DC, 2003; 516–527.
37.
TessariP. Regulation of splanchnic protein synthesis by enteral feeding. Protein, Peptides and Amino Acids in Enteral Nutrition. FürstP, YoungVR. Nestec/Vevey & S Karger: Basel, Switzerland, 2000; 47–61.
38.
Lopez-PedrosaJM, TorresMI, FernándezMI, RíosA, GilA. Severe malnutrition alters lipid composition and fatty acid profile of small intestine in newborn piglets. J Nutr, 1998; 128:224–233.
